Yahoo Finance9d
Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial
DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...
ETF Daily News10d
Trinity Biotech (NASDAQ:TRIB) Now Covered by Analysts at StockNews.com
Shares of TRIB opened at $0.86 on Thursday. Trinity Biotech has a one year low of $0.74 and a one year high of $3.55. The company has a market cap of $15.56 million, a PE ratio of -0.38 and a beta ...
Investing9d
Trinity Biotech reports leap in CGM system accuracy
DUBLIN - Trinity Biotech plc (NASDAQ:TRIB), a leader in diabetes management solutions currently trading at $0.86 per share, has announced significant enhancements in the performance of its ...
Finanznachrichten9d
Trinity Biotech plc: Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial
Zeit Aktuelle Nachrichten Di Trinity Biotech-Aktie erreicht 52-Wochen-Tief bei 0,74 US-Dollar 06.02. TRINITY BIOTECH PLC - 6-K, Report of foreign issuer 06.02. Trinity Biotech reports leap in CGM ...
Yahoo Finance9d
Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial
DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...
Investing9d
Trinity Biotech reports leap in CGM system accuracy
DUBLIN - Trinity Biotech plc (NASDAQ:TRIB), a leader in diabetes management solutions currently trading at $0.86 per share, has announced significant enhancements in the performance of its continuous ...
Business Insider9d
Trinity Biotech reports findings from latest pre-pivotal trial on CGM system
Trinity Biotech (TRIB) announced new findings from its latest pre-pivotal trial, highlighting significant improvements in first-day performance for its next-generation continuous glucose ...
Investing11d
Trinity Biotech secures US funding for HIV tests
DUBLIN, Ireland - Trinity Biotech plc (NASDAQ:TRIB), a leading provider of diagnostic solutions for the healthcare industry, today announced the continuation of U.S. government funding for its HIV ...
Yahoo Finance3d
Trinity Biotech plc (TRIB)
Trinity Biotech’s patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc ...
Investing11d
Trinity Biotech secures US funding for HIV tests
DUBLIN, Ireland - Trinity Biotech plc (NASDAQ:TRIB), a leading provider of diagnostic solutions for the healthcare industry, today announced the continuation of U.S. government funding for its HIV ...
Taiwan News9d
Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial
Trinity Biotech’s patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029 DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc ...